ACRO Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	770.67	191.75	544.16	281.85	32.26
Short-Term Investments	207.2	307.2	35.07	35.01	30.71
Cash & Short-Term Investments	977.87	498.95	579.23	316.85	62.97
Cash Growth	95.99%	-13.86%	82.81%	403.18%	-46.08%
Accounts Receivable	3.13	7.87	4.83	10.3	6.23
Other Receivables	0.96	2.15	3.39	0.17	0.08
Receivables	4.09	10.02	8.23	10.47	6.31
Inventory	12.7	10.7	9.51	12.51	14.63
Prepaid Expenses	11.24	9.71	10.85	11.01	18.27
Total Current Assets	1,006	529.38	607.81	350.84	102.17
Property, Plant & Equipment	53.7	56.23	45.81	21.89	26.39
Long-Term Investments	47.46	46.06	47.39	13.74	13.24
Other Intangible Assets	6.91	6.33	8.47	8.01	7.97
Other Long-Term Assets	18.66	17.32	7.25	4.05	1.51
Total Assets	1,133	655.33	716.74	398.53	151.29
Accounts Payable	1.03	0.75	0.95	1.21	0.11
Accrued Expenses	-	9.85	8.09	7.72	7.53
Current Portion of Leases	2.16	5.26	5.25	3.67	3.39
Current Unearned Revenue	0.88	2.5	0.19	0.08	0.31
Other Current Liabilities	15.6	0.1	0.33	-	-
Total Current Liabilities	19.68	18.46	14.81	12.68	11.34
Long-Term Leases	8.43	10.59	15.85	7.25	9.93
Total Liabilities	28.11	29.05	30.66	19.92	21.27
Common Stock	712.18	612.18	612.18	512.18	354.33
Additional Paid-In Capital	713.52	251.39	250	160.3	9.56
Retained Earnings	-319.37	-236.71	-174.62	-293.5	-232.62
Comprehensive Income & Other	-1.82	-0.59	-1.48	-0.37	-1.25
Shareholders' Equity	1,105	626.28	686.08	378.61	130.02
Total Liabilities & Equity	1,133	655.33	716.74	398.53	151.29
Total Debt	10.59	15.85	21.1	10.92	13.32
Net Cash (Debt)	967.28	483.1	558.13	305.93	49.65
Net Cash Growth	100.22%	-13.44%	82.43%	516.20%	-51.44%
Net Cash Per Share	15.80	7.89	10.59	6.46	1.40
Filing Date Shares Outstanding	61.23	61.22	61.22	51.22	35.43
Total Common Shares Outstanding	61.23	61.22	61.22	51.22	35.43
Working Capital	986.22	510.92	593	338.16	90.83
Book Value Per Share	18.04	10.23	11.21	7.39	3.67
Tangible Book Value	1,098	619.94	677.61	370.6	122.05
Tangible Book Value Per Share	17.92	10.13	11.07	7.24	3.44
Machinery	-	59.3	45.42	43.94	41.93
Construction In Progress	-	0.63	16.51	-	-
Leasehold Improvements	-	59.04	36.36	36.35	36.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.